|
Variable
|
Diabetes patients w/o IR
|
Diabetes patients w/ IR
|
Healthy subjects
|
P value
|
|---|
|
(n = 103)
|
(n = 310)
|
(n = 130)
|
|---|
|
Age (years)
|
63.55 ± 4.60
|
64.24 ± 4.66
|
64.39 ± 6.17
|
0.402
|
|
Gendera
| | | |
0.924
|
|
Male
|
25 (24.3)
|
74 (23.9)
|
29 (22.3)
| |
|
Female
|
78 (75.7)
|
236 (76.1)
|
101 (77.7)
| |
|
BMI (kg/m2)
|
23.65 ± 3.66
|
24.20 ± 3.86
|
23.76 ± 3.53
|
0.333
|
|
Smokinga
|
11 (10.7)
|
39 (12.7)
|
45 (11.5)
|
0.857
|
|
Cr (μmol/L)
|
78.56 ± 20.12
|
78.80 ± 17.79
|
77.15 ± 18.32
|
0.571
|
|
TG (mmol/L)
|
1.61 ± 0.93
|
2.16 ± 1.53
|
1.72 ± 1.53
|
<0.001
|
|
TC (mmol/L)
|
5.32 ± 1.10
|
6.00 ± 6.31
|
5.57 ± 1.42
|
0.413
|
|
HDL (mmol/L)
|
1.37 ± 0.22
|
1.42 ± 0.33
|
1.44 ± 0.83
|
0.527
|
|
LDL (mmol/L)
|
2.92 ± 0.80
|
3.15 ± 0.90
|
3.09 ± 0.91
|
0.083
|
|
Fins (mmol/L)
|
4.97 ± 1.87
|
14.25 ± 10.72
|
8.21 ± 6.23
|
<0.001
|
|
FPG (mmol/L)
|
6.55 ± 2.09
|
8.84 ± 3.97
|
5.25 ± 2.26
|
<0.001
|
|
HbA1c (mmol/L)
|
7.25 ± 1.84
|
8.02 ± 2.29
|
5.99 ± 1.49
|
<0.001
|
|
Microalbuminuria
|
17.67 ± 24.98
|
25.58 ± 35.73
|
19.00 ± 23.91
|
0.030
|
|
IR
|
1.35 ± 0.41
|
5.32 ± 4.95
|
1.87 ± 1.70
|
<0.001
|
|
NLR
|
1.71 ± 0.50
|
2.37 ± 0.61
|
1.42 ± 0.30
|
<0.001
|
|
Neutrophil
|
3.53 ± 1.33
|
4.17 ± 3.56
|
2.76 ± 0.94
|
<0.001
|
|
Lymphocyte
|
2.12 ± 0.68
|
1.81 ± 1.15
|
2.21 ± 0.35
|
<0.001
|
|
WBC
|
5.72 ± 1.54
|
6.20 ± 1.62
|
5.19 ± 1.16
|
<0.001
|
- All parameters were expressed as mean ± SD (minimum–maximum) values unless otherwise stated. P < 0.05 was accepted as the level of significance.
- aData were expressed as number (%).
- BMI, body mass index; Cr, creatinine; TG, triglycerides; TC, Total cholesterol; HDL, high-density lipoprotein; LDL, low-density lipoprotein.
